Answers are grounded in this paper and cite their sources.
CLINICAL QUESTION: In patients with respiratory tract infection, is measurement of procalcitonin to guide antibiotic prescriptions associated with reduced antibiotic exposure without increases in all-cause mortality or treatment failure? BOTTOM LINE: The measurement of procalcitonin to guide initiation and duration of antibiotic treatment in patients with respiratory tract infections of varying severity is associated with lower antibiotic exposure without increasing all-cause mortality or treatment failure.
No takes yet. Share an insight, caveat, or question.
Schüetz et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: